ArticleDiabetes, obesity & metabolism2019

Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answers.

Jeff Y Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.